双胎妊娠中孕酮、子宫托或宫颈环扎预防早产:系统综述与荟萃分析
该系统综述与荟萃分析纳入23项随机对照试验共6626例双胎妊娠孕妇,评估孕酮、宫颈环扎或子宫托预防早产的效果。与对照组相比,各干预均未显著降低<34周或<37周早产及新生儿死亡风险;阴道孕酮组<34周早产RR 0.82(95%CI 0.64-1.05,7项研究,I²=36%),但极低出生体重(<1500 g)和机械通气等次要结局有显著改善。
要点
- 双胎妊娠中孕酮、宫颈环扎或子宫托均未显著降低<34周或<37周早产风险。
- 阴道孕酮组<34周早产RR 0.82(95%CI 0.64-1.05,7项研究,I²=36%),未达统计学显著。
- 阴道孕酮组极低出生体重(<1500 g)RR 0.71(95%CI 0.52-0.98)和机械通气RR 0.61(95%CI 0.45-0.82)显著降低。
核心结论
- 在双胎妊娠中,尽管没有一种干预措施对预防早产及其后遗症有益,但阴道孕酮改善了一些重要的次要结局。
研究设计与样本
- 系统综述与荟萃分析,检索Medline、EMBASE、CINAHL、Cochrane中央对照试验注册库和ISI Web of Science,无语言限制,截至2016年1月25日。
- 纳入23项随机对照试验,共6626例双胎妊娠孕妇,均为无症状性早产临产征象者。
- 除3项外,其余试验均被认为偏倚风险低。
- 采用Cochrane偏倚风险评估工具评价研究质量,进行配对逆方差随机效应荟萃分析。
主要发现
- 与对照组相比,孕酮、宫颈环扎或子宫托均未显著降低<34周或<37周早产或新生儿死亡风险(主要结局)。
- 阴道孕酮组<34周早产RR 0.82(95%CI 0.64-1.05,7项研究,I²=36%)。
- 阴道孕酮组极低出生体重(<1500 g)RR 0.71(95%CI 0.52-0.98,4项研究,I²=46%)。
- 阴道孕酮组机械通气RR 0.61(95%CI 0.45-0.82,4项研究,I²=22%)。
临床怎么用
- 原文结论未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: About half of twin pregnancies deliver preterm, and it is unclear whether any intervention reduces this risk. OBJECTIVES: To assess the evidence for the effectiveness of progesterone, cerclage, and pessary in twin pregnancies. SEARCH STRATEGY: We searched Medline, EMBASE, CINAHL, Cochrane Central Register of Controlled Trials, and ISI Web of Science, without language restrictions, up to 25 January 2016. SELECTION CRITERIA: Randomised controlled trials of progesterone, cerclage, or pessary for preventing preterm birth in women with twin pregnancies, without symptoms of threatened preterm labour. DATA COLLECTION AND ANALYSIS: Two independent reviewers extracted data using a piloted form. Study quality was appraised with the Cochrane Risk of Bias tool. We performed pairwise inverse variance random-effects meta-analyses. MAIN RESULTS: We included 23 trials (all but three were considered to have a low risk of bias) comprising 6626 women with twin pregnancies. None of the interventions significantly reduced the risk of preterm birth overall at <34 or <37 weeks of gestation, or neonatal death, our primary outcomes, compared to a control group. In women receiving vaginal progesterone, the relative risk (RR) of preterm birth <34 weeks of gestation was 0.82 (95% CI 0.64-1.05, seven studies, I2 36%), with a significant reduction in some key secondary outcomes, including very low birthweight (<1500 g, RR 0.71, 95% CI 0.52-0.98, four studies, I2 46%) and mechanical ventilation (RR 0.61, 95% CI 0.45-0.82, four studies, I2 22%). CONCLUSION: In twin gestations, although no overarching intervention was beneficial for the prevention of preterm birth and its sequelae, vaginal progesterone improved some important secondary outcomes. TWEETABLE ABSTRACT: Vaginal progesterone may be beneficial in twin pregnancies, but not 17-OHPC, cerclage, or pessary.
引用
- Jarde A, Lutsiv O, Park CK, et al. Preterm birth prevention in twin pregnancies with progesterone, pessary, or cerclage: a systematic review and meta-analysis. BJOG. 2017. PMID: 28176485. doi:10.1111/1471-0528.14513
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。